Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
Claritas Pharmaceuticals (CLAZF) Stock Price & Analysis
25 Followers
CLAZF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume250.00
Average Volume (3M)N/A
Market Cap
$825.76K
Enterprise Value$1.38M
Total Cash (Recent Filing)$2.00K
Total Debt (Recent Filing)$548.00K
Price to Earnings (P/E)N/A
Beta1943.62
Next Earnings
Jun 02, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,786,585
10 Day Avg. Volume25
30 Day Avg. VolumeN/A
Standard Deviation31.48
R-Squared0.00024
Alpha11.86
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.13
Enterprise Value/Ebitda-0.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
65.13%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
34.87% Public Companies and
Individual Investors
CLAZF FAQ
What was Claritas Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Claritas Pharmaceuticals’s market cap?
Currently, no data Available
When is Claritas Pharmaceuticals’s upcoming earnings report date?
Claritas Pharmaceuticals’s upcoming earnings report date is Jun 02, 2023 which is 337 days ago.
How were Claritas Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Claritas Pharmaceuticals overvalued?
According to Wall Street analysts Claritas Pharmaceuticals’s price is currently Overvalued.
Does Claritas Pharmaceuticals pay dividends?
Claritas Pharmaceuticals does not currently pay dividends.
What is Claritas Pharmaceuticals’s EPS estimate?
Claritas Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Claritas Pharmaceuticals have?
Claritas Pharmaceuticals has 37,786,587 shares outstanding.
What happened to Claritas Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Claritas Pharmaceuticals?
Currently, no hedge funds are holding shares in CLAZF
---
Company Description
Claritas Pharmaceuticals
Kalytera Therapeutics, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bon fracture healing; osteogenesis imperfecta; osteoporosis; and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in Novato, CA.
---
---